Dynamics of Vaginal Microbiota Before, During and After Episodes of Bacterial Vaginosis Original paper
Researched by:
-
Divine Aleru
ID
Divine Aleru
Read MoreI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.
-
Bacterial Vaginosis
Bacterial Vaginosis
Bacterial vaginosis (BV) is caused by an imbalance in the vaginal microbiota, where the typically dominant Lactobacillus species are significantly reduced, leading to an overgrowth of anaerobic and facultative bacteria.
-
Divine Aleru
Read More
Researched by:
-
Divine Aleru
ID
Divine Aleru
Read More
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
Divine Aleru
What Was Studied?
This study investigated the daily fluctuations of vaginal microbiota before, during, and after bacterial vaginosis (BV) episodes. Researchers aimed to understand how microbial communities shift over time, particularly in symptomatic and asymptomatic BV cases. They sought to identify microbial patterns that could predict BV onset, persistence, and resolution.
Who Was Studied?
The study followed 25 women over 10 weeks, including 15 with symptomatic BV, six with asymptomatic BV, and four without BV. Participants self-collected vaginal samples daily, which researchers analyzed using 16S rRNA sequencing. The study also recorded vaginal symptoms, menstrual cycle phases, and sexual behaviors to assess how these factors influenced microbiota changes.
Key Findings and Microbial Associations
The study revealed that vaginal microbiota exhibit significant daily fluctuations, especially in women with BV. Before BV episodes, microbial diversity increased, with a rise in anaerobes such as Gardnerella vaginalis, Atopobium vaginae, Prevotella spp., and Megasphaera spp.. Women with symptomatic BV showed a notable decline in Lactobacillus crispatus, while Lactobacillus iners persisted at low levels, suggesting its role in transitional microbial states.
During symptomatic BV, bacterial communities became more heterogeneous, with a dominance of strict anaerobes and a rise in vaginal pH. Some women experienced rapid shifts in microbiota, while others maintained a stable but Lactobacillus-depleted state. Interestingly, after antibiotic treatment, most women’s microbiota temporarily shifted toward a Lactobacillus-dominated state, particularly L. iners. However, within 2-4 weeks, many reverted to their pre-treatment microbial profiles, indicating a high risk of BV recurrence.
Implications of the Study
This study highlights the dynamic nature of vaginal microbiota and reinforces the need for improved BV management strategies. Since BV-associated bacteria can persist and re-emerge despite treatment, future therapies should focus on long-term microbial stabilization rather than short-term symptom relief. The findings suggest that monitoring microbiota changes over time could help predict BV recurrence and guide personalized treatment strategies.
Additionally, the study highlights the limitations of current diagnostic methods, such as Amsel’s criteria and Nugent scoring, which do not capture daily microbial shifts. Incorporating molecular techniques into routine diagnostics could improve BV detection and allow for earlier intervention by identifying microbial imbalances before symptoms develop. This approach could also help tailor treatment strategies, reduce recurrence rates, and support long-term vaginal microbiome stability.
Bacterial Vaginosis
Bacterial vaginosis (BV) is caused by an imbalance in the vaginal microbiota, where the typically dominant Lactobacillus species are significantly reduced, leading to an overgrowth of anaerobic and facultative bacteria.
Amsel’s Criteria
Amsel's Criteria is a clinically established diagnostic method for bacterial vaginosis, offering a practical and accessible alternative to laboratory-based approaches. It evaluates four key clinical indicators, ensuring timely diagnosis and intervention in outpatient settings.
Nugent Score
The Nugent Score is a standardized Gram stain-based scoring system used to diagnose bacterial vaginosis (BV) by assessing key bacterial morphotypes in vaginal samples. With its high specificity, it remains a gold standard in microbiome research, though its complexity and need for trained personnel make it less common in routine clinical practice.